NAVIGATION
Cell and Gene Therapy Strategy Meeting Europe 2018

Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Cell and Gene Therapy.

Register Now
26th September 2018, Radisson Blu Zurich, Switzerland
2018-09-26 7:30:00 2018-09-26 19:00:00 Europe/London Cell and Gene Therapy Strategy Meeting Europe 2018 26th September 2018, Radisson Blu Zurich, Switzerland Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Cell and Gene Therapy. https://proventainternational.com/cell-gene-therapy-eu/ Radisson Blu Zurich Ambreen Anweer aa@proventainternational.com

Agenda

The Cell and Gene Therapy Roundtable Discussions Strategy Meeting is free to attend for qualified end-users.These include Senior Executives of Cell and Gene Therapy (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities.

Thought leaders who will benefit from attending include Chief Executive Officer, Chief Scientific Officer, SVPs, EVPs, VPs, Executive Director, Director and Global Head responsible for:
– Cell Therapy, Cell Engineering, Biotherapeutics, Regenerative Medicine, Immune Deficiencies, CAR-T, Cellular Immunotherapy, Supply Chain, and Manufacturing.

Those who do not qualify for complimentary passes, including vendors, exchanges, consultancies and other service providers, can apply here.

Cell and Gene Therapy Europe 2018

REQUEST AGENDA

Media Partners

Testimonials

Clinical Trial Supply Chain Strategy Meeting US East Coast 2016

Pharma Supply Chain EU 2016 , Return on Investment attained at the meeting and why they are coming back

Pharma Supply Chain EU 2016 , What they think of the roundtable discussion format

Pharma Supply Chain EU 2016 , Level of delegation, attendee diversity and seniority

Pharma Supply Chain EU 2016 , What they think of the 1-1 prequalified business meetings

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger, VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division,Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager,EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO,Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

Pharma Supply Chain EU 2016 , Return on Investment attained at the meeting and why they are coming back

Clinical Trial Supply Chain Strategy Meeting US East Coast 2016,

Pharma Supply Chain EU 2016 , Return on Investment attained at the meeting and why they are coming back

Pharma Supply Chain EU 2016 , What they think of the roundtable discussion format

Pharma Supply Chain EU 2016 , Level of delegation, attendee diversity and seniority

Pharma Supply Chain EU 2016 , What they think of the 1-1 prequalified business meetings

Samuel T. Labrie, VP Corporate Development, Myriad RBM

Kam Dhaliwal, SVP Services & Alliances, Horizon Discovery

Matt Hersch, Clinical Operations Manager, GW Pharmaceuticals

Rainer Metzger, VP Global Business Development Pharma, Qiagen

Dilsaid Babayigit, Founder & CEO, Ageneo

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division,Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager,EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO,Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

Pharma Supply Chain EU 2016 , Return on Investment attained at the meeting and why they are coming back

Location

Radisson Blu Hotel Rondellstrasse, 8058 Zürich
Switzerland

Date: Sep 26, 2017

Book your seat for the Cell and Genetherapy Europe 2018

DELEGATE REGISTRATION